000			01933 a2200505 4500
005			20250516160232.0
264		0	_c20140228
008			201402s 0 0 eng d
022			_a1815-7920
024	7		_a10.5588/ijtld.13.0178 _2doi
040			_aNLM _beng _cNLM
100	1		_aPorcel, J M
245	0	0	_aXpert® MTB/RIF in pleural fluid for the diagnosis of tuberculosis. _h[electronic resource]
260			_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _cSep 2013
300			_a1217-9 p. _bdigital
500			_aPublication Type: Evaluation Study; Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAntitubercular Agents _xtherapeutic use
650	0	4	_aAutomation, Laboratory
650	0	4	_aBacterial Proteins _xgenetics
650	0	4	_aCase-Control Studies
650	0	4	_aDNA, Bacterial _xisolation & purification
650	0	4	_aDNA-Directed RNA Polymerases
650	0	4	_aDrug Resistance, Bacterial _xgenetics
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLikelihood Functions
650	0	4	_aMale
650	0	4	_aMycobacterium tuberculosis _xdrug effects
650	0	4	_aOdds Ratio
650	0	4	_aPleural Effusion _xmicrobiology
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aPredictive Value of Tests
650	0	4	_aProspective Studies
650	0	4	_aRifampin _xtherapeutic use
650	0	4	_aSpain
650	0	4	_aTuberculosis, Pleural _xdiagnosis
700	1		_aPalma, R
700	1		_aValdés, L
700	1		_aBielsa, S
700	1		_aSan-José, E
700	1		_aEsquerda, A
773	0		_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 17 _gno. 9 _gp. 1217-9
856	4	0	_uhttps://doi.org/10.5588/ijtld.13.0178 _zAvailable from publisher's website
999			_c22892778 _d22892778